Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Chief Financial Officer bought 750 shares at an average $8.95 ($6,714)
  5. 4 Open-market buy President & CEO bought 2,000 shares at $8.50 ($16,997)
  6. 4 Open-market buy Director bought 1,000 shares at $7.96 ($7,959)
  7. 4 Open-market buy Director bought 1,700 shares at an average $8.00 ($13,602)
  8. 4 Open-market buy CSO/CMO bought 1,250 shares at $8.02 ($10,025)
  9. 4 Open-market buy Chief Financial Officer bought 1,250 shares at $7.97 ($9,961)
  10. 4 Open-market buy President & CEO bought 14,600 shares at an average $8.01 ($116,941)
  11. 4 Open-market buy Director bought 3,500 shares at an average $7.88 ($27,570)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 19 · 364 filings